1-7 of 7
Olivier Lantz
Close
Sort by
Journal Articles

Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP

Stéphane Gérart, Sophie Sibéril, Emmanuel Martin, Christelle Lenoir, Claire Aguilar, Capucine Picard, Olivier Lantz, Alain Fischer, Sylvain Latour
Journal: Blood
Blood (2013) 121 (4): 614–623.
https://doi.org/10.1182/blood-2012-09-456095
Published: 2013
Includes: Supplemental data
Journal Articles

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8 + T cells

Lucy J. Walker, Yu-Hoi Kang, Matthew O. Smith, Hannah Tharmalingham, Narayan Ramamurthy, Vicki M. Fleming, Natasha Sahgal, Alistair Leslie, Ye Oo, Alessandra Geremia, Thomas J. Scriba, Willem A. Hanekom, Georg M. Lauer, Olivier Lantz, David H. Adams, Fiona Powrie, Eleanor Barnes, Paul Klenerman
Journal: Blood
Blood (2012) 119 (2): 422–433.
https://doi.org/10.1182/blood-2011-05-353789
Published: 2012
Includes: Supplemental data
Journal Articles

Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161 hi IL-17–secreting T cells

Mathilde Dusseaux, Emmanuel Martin, Nacer Serriari, Isabelle Péguillet, Virginie Premel, Delphine Louis, Maud Milder, Lionel Le Bourhis, Claire Soudais, Emmanuel Treiner, Olivier Lantz
Journal: Blood
Blood (2011) 117 (4): 1250–1259.
https://doi.org/10.1182/blood-2010-08-303339
Published: 2011
Journal Articles

Antigen-specific T-T interactions regulate CD4 T-cell expansion

Julie Helft, Alexandra Jacquet, Nathalie T. Joncker, Isabelle Grandjean, Guillaume Dorothée, Adrien Kissenpfennig, Bernard Malissen, Polly Matzinger, Olivier Lantz
Journal: Blood
Blood (2008) 112 (4): 1249–1258.
https://doi.org/10.1182/blood-2007-09-114389
Published: 2008
Includes: Supplemental data
Journal Articles

Imatinib Mesylate Reduces Rituximab-Induced Tumor Growth Inhibition In Vivo on EBV-Associated Human B-Cell Lymphoma.

Fariba Némati, PhD, Claire Mathiot, MD, Isabelle Grandjean, PhD, Olivier Lantz, MD, PhD, Vincent Bordier, Sébastien Dewulf, Richard Ekue, James P. Di Santo, PhD, Marie-France Poupon, MD, PhD, Didier Decaudin, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2360.
https://doi.org/10.1182/blood.V110.11.2360.2360
Published: 2007
Journal Articles

CD4 cells can be more efficient at tumor rejection than CD8 cells

Ainhoa Perez-Diez, Nathalie T. Joncker, Kyungho Choi, William F. N. Chan, Colin C. Anderson, Olivier Lantz, Polly Matzinger
Journal: Blood
Blood (2007) 109 (12): 5346–5354.
https://doi.org/10.1182/blood-2006-10-051318
Published: 2007
Includes: Supplemental data
Journal Articles

Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells

Francesco Colucci, Sandrine I. Samson, Rodney P. DeKoter, Olivier Lantz, Harinder Singh, James P. Di Santo
Journal: Blood
Blood (2001) 97 (9): 2625–2632.
https://doi.org/10.1182/blood.V97.9.2625
Published: 2001